Abstract:Mouse and human genetic data suggests that Wnt5a is required for jaw development but the specific role in facial skeletogenesis is unknown. We mapped expression of WNT5A in the developing chicken skull and found that the highest expression was in early Meckel's cartilage but by stage 35 expression was decreased to background. We focused on chondrogenesis by targeting a retrovirus expressing WNT5A to the mandibular prominence prior to cell differentiation. Unexpectedly, there were no phenotypes in the first 6days following injection; however later the mandibular bones and Meckel's cartilage were reduced or missing on the treated side. To examine the effects on cartilage differentiation we treated micromass cultures from mandibular mesenchyme with Wnt5a-conditioned media (CM). Similar to in vivo viral data, cartilage differentiates normally, but, after 6days of culture, nearly all Alcian blue staining is lost. Collagen II and aggrecan were also decreased in treated cultures. The matrix loss was correlated with upregulation of metalloproteinases, MMP1, MMP13, and ADAMTS5 (codes for Aggrecanase). Moreover, Marimastat, an MMP and Aggrecanase inhibitor rescued cartilage matrix in Wnt5a-CM treated cultures. The pathways mediating these cartilage and RNA changes were investigated using luciferase assays. Wnt5a-CM was a potent inhibitor of the canonical pathway and strongly activated JNK/PCP signaling. To determine whether the matrix loss is mediated by repression of canonical signaling or activation of the JNK pathway we treated mandibular cultures with either DKK1, an antagonist of the canonical pathway, or a small molecule that antagonizes JNK signaling (TCS JNK 6o). DKK1 slightly increased cartilage formation and therefore suggested that the endogenous canonical signaling represses chondrogenesis. To test this further we added an excess of Wnt3a-CM and found that far fewer cartilage nodules differentiated. Since DKK1 did not mimic the effects of Wnt5a we excluded the canonical pathway from mediating the matrix loss phenotype. The JNK antagonist partially rescued the Wnt5a phenotype supporting this non-canonical pathway as the main mediator of the cartilage matrix degradation. Our study reveals two new roles for WNT5A in development and disease: 1) to repress canonical Wnt signaling in cartilage blastema in order to promote normal differentiation and 2) in conditions of excess to stimulate degradation of mature cartilage matrix via non-canonical pathways.

METTL5 Regulates Cranial Suture Fusion Via Wnt Signaling

METTL3-dependent m 6 A modification of PSEN1 mRNA regulates craniofacial development through the Wnt/β-catenin signaling pathway

Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function

METTL3 Modulates Ctsk+ Lineage Supporting Cranial Osteogenesis via Hedgehog

TET Enzymes Regulate Skeletal Development Through Increasing Chromatin Accessibility of RUNX2 Target Genes

Dual functions for WNT5A during cartilage development and in disease

Single-cell Transcriptomic Signatures and Gene Regulatory Networks Modulated by Wls in Mammalian Midline Facial Formation and Clefts.

In‐frame Deletion of SMC5 Related with the Phenotype of Primordial Dwarfism, Chromosomal Instability and Insulin Resistance

Embryonic inhibition of colony-stimulating factor 1 receptor induces enlarged cartilaginous zone of the midpalatal suture in postnatal mice

The Meckel-Gruber syndrome protein TMEM67 controls basal body positioning and epithelial branching morphogenesis in mice via the non-canonical Wnt pathway

Metabolic Rewiring During Bone Development Underlies Trna M'g-Associated ' G-associated Primordial Dwarfism

Prmt1 Regulates Craniofacial Bone Formation Upstream of Msx1

Tcf12 controls dynamic calvarial bone growth and motor learning in mice

Loss of M6a Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression

Cranial Suture Regeneration Mitigates Skull and Neurocognitive Defects in Craniosynostosis

Smad7 Modulates Tgf Beta Signaling During Cranial Suture Development To Maintain Suture Patency

The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development.

PRMT1-SFPQ regulates intron retention to control matrix gene expression during craniofacial development

Cdh1 Regulates Craniofacial Development Via Apc-Dependent Ubiquitination and Activation of Goosecoid

The Balance of WNT and FGF Signaling Influences Mesenchymal Stem Cell Fate During Skeletal Development

The E3 Ubiquitin Ligase Wwp2 Regulates Craniofacial Development Through Mono-Ubiquitylation of Goosecoid